Betaseron



Indications and Reactions:

Role Indications Reactions
Primary
Multiple Sclerosis 40.9%
Relapsing-remitting Multiple Sclerosis 26.4%
Drug Use For Unknown Indication 6.4%
Secondary Progressive Multiple Sclerosis 5.3%
Product Used For Unknown Indication 4.4%
Depression 2.4%
Premedication 2.2%
Hypertension 2.1%
Pain 1.9%
Ms 1.0%
Anxiety 0.9%
Headache 0.8%
Insomnia 0.8%
Muscle Spasms 0.8%
Primary Progressive Multiple Sclerosis 0.8%
Osteoporosis 0.6%
Migraine 0.6%
Prophylaxis 0.6%
Fatigue 0.6%
Convulsion 0.5%
Death 11.6%
Multiple Sclerosis 8.6%
Vomiting 7.6%
Pyrexia 6.7%
Weight Decreased 6.2%
Injection Site Pain 5.9%
Influenza Like Illness 5.5%
Multiple Sclerosis Relapse 5.5%
Pain 5.0%
Injection Site Erythema 4.6%
Tremor 4.4%
Urinary Tract Infection 4.0%
Myocardial Infarction 3.9%
Weight Increased 3.4%
Depression 3.3%
Pain In Extremity 3.2%
Injection Site Reaction 3.0%
Adverse Drug Reaction 2.9%
Fatigue 2.6%
Vision Blurred 2.4%
Secondary
Relapsing-remitting Multiple Sclerosis 29.5%
Multiple Sclerosis 27.9%
Secondary Progressive Multiple Sclerosis 6.0%
Drug Use For Unknown Indication 5.7%
Premedication 4.6%
Depression 4.2%
Hypertension 3.0%
Pain 2.9%
Product Used For Unknown Indication 2.6%
Prophylaxis 1.8%
Muscle Spasms 1.6%
Insomnia 1.5%
Headache 1.5%
Anxiety 1.4%
Primary Progressive Multiple Sclerosis 1.3%
Convulsion 1.0%
Osteoporosis 0.9%
Trigeminal Neuralgia 0.9%
Hypothyroidism 0.9%
Fatigue 0.8%
Vomiting 12.7%
Weight Decreased 11.4%
Pyrexia 7.9%
Multiple Sclerosis 6.3%
Urinary Tract Infection 6.0%
Tremor 5.9%
Pain 5.4%
Muscular Weakness 4.2%
Pain In Extremity 4.2%
Weight Increased 4.1%
Urticaria 4.1%
Somnolence 4.0%
Influenza Like Illness 3.8%
Multiple Sclerosis Relapse 3.5%
White Blood Cell Count Decreased 3.2%
Nausea 2.9%
Suicidal Ideation 2.9%
White Blood Cell Count Increased 2.7%
Injection Site Pain 2.4%
Staphylococcal Infection 2.4%
Concomitant
Multiple Sclerosis 51.5%
Product Used For Unknown Indication 20.0%
Drug Use For Unknown Indication 5.7%
Pain 3.6%
Gait Disturbance 2.5%
Depression 2.4%
Multiple Myeloma 2.3%
Fatigue 1.5%
Relapsing-remitting Multiple Sclerosis 1.4%
Contraception 1.1%
Arthritis 0.9%
Convulsion 0.9%
Hypertension 0.9%
Muscle Spasticity 0.8%
Premedication 0.8%
Hypersensitivity 0.8%
Hypertonic Bladder 0.8%
Muscle Spasms 0.7%
Osteoporosis 0.7%
Smoking Cessation Therapy 0.7%
Multiple Sclerosis Relapse 9.6%
Vomiting 7.3%
Death 6.9%
Weight Increased 6.9%
Urinary Tract Infection 6.4%
Multiple Sclerosis 6.0%
Drug Ineffective 5.5%
Stress 5.5%
Tremor 5.5%
Visual Impairment 5.5%
Fatigue 4.1%
Headache 4.1%
Nocturia 4.1%
Convulsion 3.7%
Weight Decreased 3.7%
Pain 3.2%
Paraesthesia 3.2%
Thrombosis 3.2%
Pulmonary Embolism 2.8%
Rash 2.8%
Interacting
Drug Use For Unknown Indication 33.3%
Insomnia 33.3%
Relapsing-remitting Multiple Sclerosis 33.3%
Loss Of Consciousness 100.0%